Abstract:The objective of this article is to review the current and emerging treatments of CKD prior to dialysis in the elderly. Worldwide, there are increasing numbers of people who are aged over 65 years. In parallel, there are increasing numbers of elderly patients presenting with chronic kidney disease (CKD), particularly in the more advanced stages. The elderly have quite different health care needs related to their associated comorbidity, frailty, social isolation, poor functional status, and cognitive decline. Clinical trials assessing treatments for CKD have usually excluded patients older than 70-75 years; therefore, it is difficult to translate current therapies recommended for younger patients with CKD across to the elderly. Many elderly people with CKD progress to end-stage kidney disease and face the dilemma of whether to undertake dialysis or accept a conservative approach supported by palliative care. This places pressure on the patient, their family, and on health care resources. The clinical trajectory of elderly CKD patients has in the past been unclear, but recent evidence suggests that many patients over 75 years of age with multiple comorbidities have greatly reduced life expectancies and quality of life, even if they choose dialysis treatment. Offering a conservative pathway supported by palliative care is a reasonable option for some patients under these circumstances. The elderly person who chooses to have dialysis will frequently have different requirements than younger patients. Kidney transplantation can still result in improved life expectancy and quality of life in the elderly, in carefully selected people. There is a genuine need for the inclusion of the elderly in CKD clinical trials in the future so we can produce evidence-based therapies for this group. In addition, new therapies to treat and slow CKD progression are needed for all age groups.

Aging and Chronic Kidney Disease: Epidemiology, Therapy, Management, and the Role of immunity

Prevalence and Related Factors of Chronic Kidney Disease (CKD) among Long-Lived Individuals (LLI) over 95 Years of Age.

Immunosenescence, Gut Dysbiosis, and Chronic Kidney Disease: Interplay and Implications for Clinical Management

Kidney Aging and Chronic Kidney Disease

Aging and Diabetic Kidney Disease: Emerging Pathogenetic Mechanisms and Clinical Implications

Senescence and the Aging Immune System as Major Drivers of Chronic Kidney Disease

Current and emerging treatment options for the elderly patient with chronic kidney disease

Inflammation and Premature Ageing in Chronic Kidney Disease

Effects of aging on renal function and regenerative capacity

Pathological mechanisms of kidney disease in ageing

Premature Aging in Chronic Kidney Disease: The Outcome of Persistent Inflammation beyond the Bounds

Treatment of chronic kidney disease in older populations

Aging Kidney and Aging-Related Disease.

The impact of population ageing on the burden of chronic kidney disease

Inflammation and premature aging in advanced chronic kidney disease

[Chronic kidney disease and accelerated aging: the role of comprehensive geriatric assessment]

Chronic Kidney Disease in the Older Adult Patient with Diabetes

Chronic Inflammation in Chronic Kidney Disease

Implication of cellular senescence in the progression of chronic kidney disease and the treatment potencies

Clinical characteristics of the chronic kidney disease in the elderly: a cross-sectional study